Alvotech
ALVOW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001898416
No open-market purchases or sales by Alvotech insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $1.16M in total; Oaktree Capital is the only superinvestor holding it.
Other share classesALVO
Q1 2023 vs. Q4 2022
How the institutions holding Alvotech changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 23 | 15 | −8 |
| Shares | 6.17M | 5.87M | −293.8K (−4.8%) |
| Value | $5.39M | $13.3M | +$7.91M (+146.7%) |
New holders (0)
Institutions that held Alvotech at the end of Q1 2023 but not at the end of Q4 2022.
None.
Sold out (8)
Institutions that held Alvotech at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| CSS LLC | 61,875 | $57.5K |
| DuPont Capital Management Corp | 18,750 | $19.9K |
| Hudson Bay Capital Management LP | 16,250 | $17.2K |
| Castle Creek Arbitrage, LLC | 12,499 | $13.7K |
| KCL Capital, L.P. | 12,254 | $11.4K |
| CNH Partners LLC | 11,394 | $10.6K |
| Wolverine Asset Management LLC | 4,345 | $4.04K |
| Clear Street LLC | 4,695 | $4.00K |